ELI LILLY & Co

Key metrics

Financial performance

Over the last 9 fiscal years ELI LILLY & Co's revenue grew from $18.31B to $65.18B, a compound annual growth rate of 15.1%. Net profit margin expanded from 14.9% to 31.7% over the same period - every figure below comes from the company's audited annual filings.

Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.

Key statistics

Latest filings

Browse the full filing history (995 filings)

Recent press releases

• Single Dose Lillys Pcsk9 Base Editor Verve 102 Reduced Pcsk9 882026-05-25

  A single dose of Lilly's PCSK9 base editor, VERVE-102, reduced PCSK9 by up to 88% and LDL-C by up to 62%, with durable effects supporting its potential as a one-time treatment for hypercholesterolemia | Eli Lilly and Company

• Results were consistent across both age groups (<65 and ≥65 years), with and without type 2 diabetes, supporting Foundayo as a treatment option across a broad adult population2026-05-22

  Foundayo (orforglipron), a once-daily pill taken without food or water restrictions, was associated with reduced body weight of up to 13% in adults 65 and older with obesity or overweight, in new analysis of ATTAIN-1/2 | Eli Lilly and Company

• Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting2026-05-21

  Lilly to showcase oncology portfolio across tumor types and treatment modalities at the 2026 American Society of Clinical Oncology Annual Meeting | Eli Lilly and Company

• Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial2026-05-21

  Lilly's triple agonist, retatrutide, delivered powerful weight loss in pivotal Phase 3 obesity trial | Eli Lilly and Company

• Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference2026-05-18

  Lilly to participate in Bernstein's 42nd Annual Strategic Decisions Conference | Eli Lilly and Company

Similar companies

The largest companies sharing ELI LILLY & Co's SEC industry classification (pharmaceutical preparations).